Case Study: Major Global Biopharmaceutical Company boosts flu vaccine uptake with CSS Corp deep analytics

Driving Vaccination Uptake among People with Diabetes Using Deep Analytics for a Global Pharma Major

CSS Corp worked with a major global biopharmaceutical company operating manufacturing facilities in 36 countries and serving customers in more than 170 countries. The client was concerned about declining flu vaccine sales and low awareness among target populations, especially people with diabetes, and wanted to understand what influenced vaccine adoption, customer behavior during flu season, and how to better predict outbreaks and support WHO-aligned vaccination compliance.

CSS Corp built a Google Cloud Platform–based analytics solution that combined simulation modeling, business intelligence dashboards, and social media analytics to forecast flu outbreaks, segment customers, and identify the best timing and messaging for vaccine interventions. By integrating survey, weather, flu trend, demographic, and sentiment data, CSS Corp delivered a real-time dashboard and predictive framework that improved decision-making, helped identify enablers to increase vaccine acceptance, and supported stronger sales performance and more targeted education efforts.